| Followers | 797 |
| Posts | 86127 |
| Boards Moderated | 3 |
| Alias Born | 12/25/2009 |
Saturday, April 24, 2021 7:03:08 PM
Thirteenth Amendment
As previously reported in our Current Report on Form 8-K filed with the SEC on February 10, 2020, we entered into a Thirteenth Amendment to Note and Warrant Purchase Agreement on February 6, 2020 (the “Thirteenth Amendment”) with the Existing Investor listed in Annex I to the Thirteenth Amendment (the “Thirteenth Amendment Investor”) and with the HealthCor Parties and certain additional Existing Investors (solely in their capacity as Majority Holders (acting together with the Thirteenth Amendment Investor) approving the Thirteenth Amendment and not as investors), pursuant to which (i) we sold and issued, for $100,000 in cash, to the Thirteenth Amendment Investor on such date an additional note, the Thirteenth Amendment Supplemental Closing Note, in the initial principal amount of $100,000, with a conversion price per share equal to $0.01 (subject to adjustment as described therein) and a maturity date of February 5, 2030; and (ii) the Majority Holders consented to the issuance of a warrant in connection with an additional loan under the Credit Agreement. The Thirteenth Amendment Investor is one of our directors.
As previously reported in our Current Report on Form 8-K filed with the SEC on February 10, 2020, we entered into a Thirteenth Amendment to Note and Warrant Purchase Agreement on February 6, 2020 (the “Thirteenth Amendment”) with the Existing Investor listed in Annex I to the Thirteenth Amendment (the “Thirteenth Amendment Investor”) and with the HealthCor Parties and certain additional Existing Investors (solely in their capacity as Majority Holders (acting together with the Thirteenth Amendment Investor) approving the Thirteenth Amendment and not as investors), pursuant to which (i) we sold and issued, for $100,000 in cash, to the Thirteenth Amendment Investor on such date an additional note, the Thirteenth Amendment Supplemental Closing Note, in the initial principal amount of $100,000, with a conversion price per share equal to $0.01 (subject to adjustment as described therein) and a maturity date of February 5, 2030; and (ii) the Majority Holders consented to the issuance of a warrant in connection with an additional loan under the Credit Agreement. The Thirteenth Amendment Investor is one of our directors.
Recent CRVW News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 06:33:37 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:36:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/06/2026 10:25:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2025 05:09:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:05:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/02/2025 06:18:05 PM
